Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
A benefit-risk assessment of class III antiarrhythmic agents
Bente Brendorp, Oledyg Pedersen,
Christian Torp-Pedersen
, Naji Sahebzadah,
Lars Køber
38
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A benefit-risk assessment of class III antiarrhythmic agents'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Risk Assessment
60%
Amiodarone
35%
dofetilide
34%
Anti-Arrhythmia Agents
33%
Pharmaceutical Preparations
29%
Atrial Fibrillation
25%
Cardiac Arrhythmias
24%
Sotalol
20%
Heart Failure
15%
Sudden Death
15%
ibutilide
12%
Mortality
10%
Torsades de Pointes
9%
Atrial Flutter
9%
Drug Therapy
8%
Primary Prevention
7%
Genetic Testing
7%
Secondary Prevention
7%
Tachycardia
6%
Myocardium
6%
Therapeutics
5%
Heart Diseases
5%
Maintenance
5%
Odds Ratio
4%
Guidelines
4%
Safety
4%
Incidence
3%
Population
2%
Chemical Compounds
Antiarrhythmic Agent
100%
Amiodarone
45%
Dofetilide
40%
Drug
38%
Sotalol
23%
Ibutilide
14%
QT Interval
14%
Refractory
7%
Safety
6%
Purity
3%
Reduction
3%
Time
2%